We are live on ! Find out more
YF

Yu Fan Portfolio holdings

AUM $97M
1-Year Est. Return 57.2%
This Fund
S&P 500
This Quarter Est. Return
-29.49%
1 Year Est. Return
+57.2%
3 Year Est. Return
-14.37%
5 Year Est. Return
-61.92%
10 Year Est. Return
–
AUM
$1.41M
AUM Growth
+$135K
Cap. Flow
+$680K
Cap. Flow %
48.22%
Top 10 Hldgs %
100%
Holding
7
New
2
Increased
1
Reduced
–
Closed
2

Top Buys

Rank Stock Value
1
SGMT icon
Sagimet Biosciences
SGMT
+$761K
2
SYRE icon
Spyre Therapeutics
SYRE
+$213K
3
PYXS icon
Pyxis Oncology
PYXS
+$161K

Top Sells

Rank Stock Value
1
CSTL icon
Castle Biosciences
CSTL
+$283K
2
APGN
Apexigen, Inc. Common Stock
APGN
+$173K

Sector Composition

Rank Sector Weight
1 Healthcare 99.14%
2 Consumer Staples 0.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SGMT icon
1
Sagimet Biosciences
SGMT
$433M
$503K 35.7%
+57,190
New +$761K
SONX
2
DELISTED
Sonendo, Inc.
SONX
$409K 28.99%
547,945
– –
SYRE icon
3
Spyre Therapeutics
SYRE
$8.68B
$348K 24.67%
20,592
+16,110
+359% +$213K
PYXS icon
4
Pyxis Oncology
PYXS
$170M
$138K 9.78%
+69,303
New +$161K
PRE icon
5
Prenetics Global
PRE
$330M
$12.1K 0.86%
1,667
– –
CSTL icon
6
Castle Biosciences
CSTL
$773M
– –
-20,592
Closed -$283K
APGN
7
DELISTED
Apexigen, Inc. Common Stock
APGN
– –
-401,757
Closed -$173K

Similar funds

ACM
Arrington Capital Management Miami, Florida $97.1M AUM
AWP
Atlas Wealth Partners Wyomissing, Pennsylvania $97.3M AUM 26.15% 1-Year Est. Return
SFO
Standard Family Office Sioux Falls, South Dakota $96.8M AUM 17.11% 1-Year Est. Return
CSW
Cogent Strategic Wealth Chicago, Illinois $97.3M AUM
TFS
truNorth Financial Services Chambersburg, Pennsylvania $96.7M AUM
FA
Fullerton Advisors Danville, California $96.6M AUM
JKSF
John & Kathleen Schreiber Foundation Lake Forest, Illinois $97.5M AUM 13.8% 1-Year Est. Return
BFA
Ballast Financial Advisors West Chester, Pennsylvania $97.5M AUM

Yu Fan's Q3 2023 Portfolio in Review

As of Q3 2023, Yu Fan held 7 positions worth $1.41M, up 11% from $1.27M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Yu Fan deployed $680K of net new capital in Q3 2023, opening 2 new positions and adding to 1 existing holding. Its largest new stake was Sagimet Biosciences: 57,190 shares worth $503K.

By sector, the portfolio is most concentrated in Healthcare at 99% of assets, up from 98% a quarter earlier, followed by Consumer Staples.

On the sell side, the most notable exit was Castle Biosciences, an estimated $283K sold.

  • Yu Fan's largest Q3 2023 buy was Sagimet Biosciences: 57,190 shares worth $503K.
  • Yu Fan added most to Spyre Therapeutics in Q3 2023, an estimated $213K increase.
  • Yu Fan fully exited Castle Biosciences in Q3 2023, selling an estimated $283K.
  • Yu Fan's ten largest holdings make up 100% of its $1.41M portfolio in Q3 2023.
  • Yu Fan opened 2 new positions and closed 2 in Q3 2023.
  • Yu Fan's portfolio value rose 11% quarter-over-quarter to $1.41M.

Based on Yu Fan's 13F filing for Q3 2023, filed 14 Nov 2023.